Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IntelGenx appoints Rajiv Khosla senior consultant

This article was originally published in Scrip

Executive Summary

Dr Rajiv Khosla has joined IntelGenx's management team in a senior consulting capacity, effective 1 January 2013. Initially, Dr Khosla will assist IntelGenx with strategic operations and business development activities, but it is anticipated that in April 2013 he will be appointed chief operating officer and chief scientific officer, both of which will be newly created positions. Dr Khosla has been serving as a member of IntelGenx's board but will resign his seat as he begins his new role. Most recently, he served as president and CEO of Orasi Medical.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC019745

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel